Dallas, TX 8/29/2011 11:00:58 PM
News / Stocks

SLLN, SPQS, TLON are included in our Top Penny Stock Gainers

SLLN, SPQS, TLON are some of today’s top penny stock gainers.

Searchlight Solutions Ltd. (PINK:SLLN) reached up 37.50% in morning trading to $.0011 with 25M shares traded. Searchlight Solutions Ltd. is a technology venture holding company that provides business development and high level management services for early stage technology companies who are pursuing the benefits of the public marketplace. Searchlight Solutions Ltd. (Pinksheets: SLLN.PK - News) today announced its subsidiary, Searchlight Scientific, Inc., is executing plans to launch video rendering services in the cloud on its High Performance Cloud Computing ("HPC2") platform. Clients are expected to be from the film and video gaming industries.

Sportsquest, Inc, (PINK:SPQS) reached up 33.33% in morning trading to $.002 with 11M shares traded. SportsQuest, Inc, is a holdings company that is focused on aquiring companies that have developed innovative products with existing inventory, equipment and contracts that are in need of strong management expertise to implement their business strategy. Sportsquest, Inc, (Pink Sheets:SPQS.pk - News) announced the formation of the corporate Advisory Board. The new members will include business leaders from diverse industry backgrounds. The board will provide valuable perspective and counsel to the executive team at Sportsquest in the areas of business development, market trends and operations.

Talon Therapeutics, Inc., (OTCBB:TLON) reached up 21.58% in morning trading to $.8875 with 140K shares traded. Talon Therapeutics, Inc. is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees. Talon Therapeutics, Inc., (OTCBB:TLON.OB - News), announced today the company has reached agreement with the U. S. Food and Drug Administration (FDA) regarding a special protocol assessment (SPA) for its planned Phase 3 study of Marqibo(R) (vincristine sulfate liposomes injection) in adults with newly diagnosed Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL).

For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com

About PennyTrader.com

PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE